Cite

HARVARD Citation

    Che, J. et al. (2022). Dexmedetomidine disrupts esophagus cancer tumorigenesis by modulating circ_0003340/miR-198/HMGA2 axis. Anti-cancer drugs. 33 (5), pp. 448-458. [Online]. 
  
Back to record